NOX enzymes as drug targets

被引：20
|
作者：
Krause, Karl-Heinz [2 ,3 ]
Lambeth, David [4 ]
Kroenke, Martin [1 ,5 ,6 ]
机构：
[1] Univ Cologne, Inst Med Mikrobiol Immunol & Hyg, D-50935 Cologne, Germany
[2] Geneva Med Fac, Ctr Med Univ, Dept Pathol & Immunol, CH-1211 Geneva, Switzerland
[3] Univ Hosp Geneva, Ctr Med Univ, Dept Genet & Lab Med, CH-1211 Geneva, Switzerland
[4] Emory Univ, Univ Med Sch, Dept Pathol & Lab Med, Atlanta, GA 30322 USA
[5] CECAD Cologne, Ctr Mol Med Cologne, Cologne, Germany
[6] German Ctr Infect Res, Cologne, Germany
来源：
CELLULAR AND MOLECULAR LIFE SCIENCES | 2012年 / 69卷 / 14期
关键词：
NADPH oxidases (NOX); Peptide inhibitors; Reactive oxygen species (ROS); NOX and disease;
D O I：
10.1007/s00018-012-1006-5
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：2279 / 2282
页数：4
相关论文
共 50 条
  • [31] NADPH Producing Enzymes as Promising Drug Targets for Chagas Disease
    Cordeiro, Artur T.
    CURRENT MEDICINAL CHEMISTRY, 2019, 26 (36) : 6564 - 6571
  • [32] Steroidogenic cytochrome P450 enzymes as drug targets
    Hartmann, Rolf
    Emmerich, Juliette
    Yin, Lina
    Ali, Amjad
    Hoyt, Scott
    Hu, Qingzhong
    van Koppen, Chris
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [33] Bacterial DNA replication enzymes as targets for antibacterial drug discovery
    Sanyal, Gautam
    Doig, Peter
    EXPERT OPINION ON DRUG DISCOVERY, 2012, 7 (04) : 327 - 339
  • [34] Lipid metabolic enzymes: emerging drug targets for the treatment of obesity
    Yuguang Shi
    Paul Burn
    Nature Reviews Drug Discovery, 2004, 3 : 695 - 710
  • [35] Lipid metabolic enzymes: Emerging drug targets for the treatment of obesity
    Shi, YG
    Burn, P
    NATURE REVIEWS DRUG DISCOVERY, 2004, 3 (08) : 695 - 710
  • [36] Genome-bound enzymes as epigenetic drug targets in cancer
    Bomsztyk, Karol
    Wang, Yuliang
    EPIGENOMICS, 2019, 11 (13) : 1463 - 1467
  • [37] NAD(P) Biosynthesis Enzymes as Potential Targets for Selective Drug Design
    Magni, G.
    Di Stefano, M.
    Orsomando, G.
    Raffaelli, N.
    Ruggieri, S.
    CURRENT MEDICINAL CHEMISTRY, 2009, 16 (11) : 1372 - 1390
  • [38] PLASMODIUM VIVAX ISOPRENOIDS BIOSYNTHESIS PATHWAY ENZYMES AS PROBABLE DRUG TARGETS
    Saxena, Vishal
    Garg, Shilpi
    Saggu, Gagandeep S.
    Pala, Zarna R.
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2017, 95 (05): : 297 - 297
  • [39] PLP-dependent enzymes as potential drug targets for protozoan diseases
    Kappes, Barbara
    Tews, Ivo
    Binter, Alexandra
    Macheroux, Peter
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2011, 1814 (11): : 1567 - 1576
  • [40] Experiences with the Shikimate-pathway enzymes as targets for rational drug design
    Coggins, JR
    Abell, C
    Evan, LB
    Frederickson, M
    Robinson, DA
    Roszak, AW
    Lapthorn, AP
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2003, 31 : 548 - 552
12345